<?xml version="1.0" encoding="UTF-8"?>
<p>In another research, Khaerunnisa, Kurniawan, Awaluddin, Suhartati, and Soetjipto (
 <xref rid="ptr6893-bib-0031" ref-type="ref">2020</xref>) investigated several herbal compounds, which are potent inhibitor of COVID‐19 M
 <sub>pro</sub> (main protease) like kaempferol (
 <bold>2</bold>), quercetin (
 <bold>3</bold>), luteolin‐7‐glucoside (
 <bold>4</bold>), demethoxycurcumin (
 <bold>5</bold>), naringenin (
 <bold>6</bold>), apigenin‐7‐glucoside (
 <bold>7</bold>), oleuropein (
 <bold>8</bold>), curcumin (
 <bold>9</bold>) catechin (
 <bold>10</bold>), epigallocatechin‐gallate (
 <bold>11</bold>), zingerol (
 <bold>12</bold>), gingerol (
 <bold>13</bold>), and allicin (
 <bold>14</bold>) (Figure 
 <xref rid="ptr6893-fig-0002" ref-type="fig">2a</xref>) isolated from some flavonoids of medicinal plants (Khaerunnisa et al., 
 <xref rid="ptr6893-bib-0031" ref-type="ref">2020</xref>). Utomo, Ikawati, and Meiyanto (
 <xref rid="ptr6893-bib-0070" ref-type="ref">2020</xref>) shows the likely inhibitory results of 
 <italic>Curcuma</italic> and 
 <italic>Citrus</italic> spp. on the replication and progress of the infection, so hesperidin (
 <bold>15</bold>) from these species may be used for the development of anti‐SARS‐CoV‐2 drugs as a treatment regime of COVID‐19 (Utomo et al., 
 <xref rid="ptr6893-bib-0070" ref-type="ref">2020</xref>). Diammonium glycyrrhizinate (
 <bold>16</bold>) (Figure 
 <xref rid="ptr6893-fig-0002" ref-type="fig">2a</xref>), a herbal compound of the sweet root, has been used to constrain the severe symptoms of COVID‐19 while this compound is in clinical use for a long time for the treatment of coughs, digestive problems, and liver infection caused by HBV.
</p>
